http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150119861-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4375
filingDate 2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59d36cbae48ce16ea3e051fa045c3e77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74255af54368f5f5f43663b74295aec0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2f8f30cbaf9d119f7882da11dc209877
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45344281f1735a52b3abb733e5b36ef5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17d5784543effd0fe526a1cbd26c533c
publicationDate 2015-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20150119861-A
titleOfInvention Agent for preventing or treating diseases of posterior part of the eye and containing tetrahydropyranyl amino cyclopentylcarbonyl tetrahydropyridopyridine derivative as active component
abstract The present invention relates to a prophylactic or therapeutic agent for a posterior segment disease comprising a compound represented by the formula (1), an enantiomer or a diastereomer thereof, or a pharmaceutically acceptable salt thereof as an active ingredient.
priorityDate 2013-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456496765

Total number of triples: 28.